Objective: To investigate the extent to which preferred drug lists and tiered formularies reflect evidence of value, as measured in published cost-utility analyses (CUAs). Methods: Using 1998-2001 ...

NYU Langone files $24M plan to upgrade hospital's cardiology facilities Patient-monitoring tech startup raises $130M for global expansion Columbia launches simulation to prep hospital executives for ...

Express Scripts Holding, a pharmacy benefit manager that negotiates drug prices for many health plans, will launch a formulary with lower list price drugs in an effort to reduce reliance on rebates ...

An Assembly bill that prevents health plans from removing a prescription drug from their formulary, or add new restrictions during a contract year, advanced to the next step Thursday. Opponents ...

FILE - Packaging for AbbVie's drug, Humira. Patients who take the autoimmune disease treatment can get some price relief when lower-cost, biosimilar versions are included on health plan formularies.

Health systems’ pharmaceutical spending is expected to rise by up to 6 percent in 2019, according to a study published in the American Journal of Health-System Pharmacy. For these organizations — ...

Insurance isn't always your friend.

Patricia Salber, MD, MBA, of The Doctor Weighs In, interviewed James D. Chambers, PhD, to discuss his findings on the impact of formulary drug exclusion policies. In August, The American Journal of ...

Recent press reports and other evidence suggest that Medicare Part D plans may be encouraging the use of brand-name drugs instead of generics. However, the scope of such practices is unclear. We ...

A key feature of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA) is its reliance on private insurers (stand alone-drug insurers and Medicare Advantage plans) to ...

The Bermuda Health Council has paused further guidance on the price of pharmaceuticals in the wake of “rapid changes” in the ...